Skip to content
healthcare.dev

Dabigatran Etexilate

NDC 0378-0266, Dabigatran Etexilate, capsule, from Mylan Pharmaceuticals Inc..

Product NDC
0378-0266
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208067
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-0266 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DABIGATRAN ETEXILATE MESYLATE150 mg/1

Pharmacologic classes

Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]

Package NDCNDC-11Package
0378-0266-910037802669160 CAPSULE in 1 BOTTLE, PLASTIC (0378-0266-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/baafb5be-ffe6-4755-a7ab-817b3c9b222d
  • NADAC price for package 00378026691

    GET /v1/drugs/nadac/00378026691

Use it

Look up 0378-0266 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-0266 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-0266. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.